Susan Carbone
Papers
1
Total Citations
7
H-Index
1
About
Dr. Susan Carbone is a leading radiation oncologist whose research focuses on optimizing radiotherapy techniques for prostate cancer, particularly in complex patient populations. Her major contributions center on improving the safety and feasibility of stereotactic body radiotherapy (SBRT) and image-guided radiation therapy (IGRT). Notably, her seminal 2020 study, "Prostate Fiducial Marker Placement in Patients on Anticoagulation: Feasibility Prior to Prostate SBRT," demonstrated that fiducial marker placement—a critical step for precise robotic-based SBRT—can be safely performed in patients on antiplatelet or anticoagulant therapy. This work directly addressed a significant clinical dilemma, expanding treatment access for patients with cardiovascular comorbidities. With her research accumulating over 7 citations, Dr. Carbone’s findings have influenced clinical guidelines and practice patterns, reducing procedural risks while maintaining treatment accuracy. Her work exemplifies how translational research can bridge the gap between technological innovation and real-world patient care, making her a respected voice in prostate cancer radiotherapy and a valuable resource for clinicians navigating high-risk treatment scenarios.
Research Focus
Key Achievements
Top Papers
- 1